If youâre looking to boost your income portfolio this week, then you may want to look at the shares listed below.
Hereâs why these ASXÂ dividend shares have been tipped as buys:
Dexus Industria REITÂ (ASX: DXI)
The first ASX dividend share that could be in the buy zone is Dexus Industria.
It is an industrial and office focused property company that was formerly known as APN Industria. Dexus Industria owns interests in office and industrial properties across the country that provide functional and affordable workspaces for businesses.
Morgans is a fan of the company. It recently commented:
DXIâs key industrial markets remain robust with the outlook for solid rental growth backed by strong tenant demand. The development pipeline also provides near and medium term upside potential. A key focus will be the leasing up of the business park assets and a potential divestment could be a positive catalyst. While the portfolio remains well positioned we acknowledge there will be near-term uncertainty around interest rates.
Its analysts currently have an add rating and $3.25 price target on the companyâs shares.
They are also forecasting attractive dividends per share of 17.3 cents in FY 2023 and 16.4 cents in FY 2024. Based on the current Dexus Industria share price of $2.70, this will mean yields of 6.4% and 6.1%, respectively.
Healthco Healthcare and Wellness REITÂ (ASX: HCW)
Another ASX dividend share that has been named as a buy is the Healthco Healthcare and Wellness REIT.
It is a real estate investment trust with a focus on hospitals, aged care, childcare, life sciences, and primary care properties.
Goldman Sachs is very positive on the company and recently named it as one of its top picks in the sector. The broker commented:
[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.
Its analysts have a conviction buy rating and $2.14 price target on its shares.
In respect to dividends, Goldman expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.65 this will mean yields of 4.5% for investors.
The post Here are 2 ASX dividend shares experts say are buys appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of September 1 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/8d1S5oM
Leave a Reply